Merck has announced that the antagonist of the calcitonin gene-related peptide (CGRP) receptor telcagepant has met the primary end points in two Phase III trials to treat migraine, which is ...

The maximum dose is 75 mg within a 24-hour period. Like the anti-CGRP monoclonal antibodies, gepants were created to target migraine specifically. These medications have been shown to be effective ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

W hen it comes to treating a chronic condition like migraine, Western medicine is the new kid on the block, relatively speaking. After all, the vast majority of today’s pharmace ...

However, combining a triptan with an NSAID or acetaminophen was less expensive than other treatments, particularly the CGRP antagonists gepants ($5994) and lasmiditan ($6668). Financial ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO ...

Mounting evidence indicates that calcitonin gene-related peptide (CGRP) has a key role in migraine, but full appreciation of the nature of its involvement has remained elusive, owing in part to a ...